We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pharmaceutical benefit manager (PBM) Medco Health Solutions has agreed to acquire
Accredo Health for $2.2 billion -- a deal that would create the nation's largest
specialty pharmacy business, Medco has announced.
Although Merck has not yet divulged its intentions
regarding the future of Vioxx, pharmaceutical analysts expect the drugmaker
to reintroduce the controversial arthritis pain treatment sometime this fall,
following the favorable recommendation issued recently by an FDA advisory panel.
The pharmaceutical markets of the 10 European Union (EU) member countries added
to the EU in 2004 have been rapidly expanding in recent years, despite more
subdued growth in the rest of the region, according to a new research report.
GlaxoSmithKline (GSK) has filed a patent infringement lawsuit in federal court
against Spectrum Pharmaceuticals to prevent Spectrum from developing a generic
version of GSK's migraine drug Imitrex.
Discovery Partners International has announced that it has signed a binding
letter of intent, subject to confirmatory due diligence, to acquire Biofrontera
Discovery GmbH, based in Heidelberg, Germany, the natural products drug discovery
subsidiary of Biofrontera AG, a privately held specialty pharma business.
Debiopharm S.A., the independent drug development company specializing in oncology,
endocrinology and niche products, has announced that it has purchased all the
outstanding shares of H3 Pharma from Montreal-based Societe Generale de Financement
du Quebec (SGF).
Drug development firm Point Therapeutics said recently it plans to sell 3.65
million of its common shares at $4.50 each in a direct offering, primarily to
institutional investors.
Nautilus Biotech a private protein pharmaceutical company announced the completion
of a Euro 7.25 million round of financing with a syndicate led by Auriga Partners.
Privately held biotech company Sciona Inc. has closed on its third round of
financing, its first since relocating from the United Kingdom to Boulder earlier
this year.